OBJECTIVES: Thoracoscore is incorporated in the new British Thoracic Society and National Institute of Health and clinical Excellence guidelines to evaluate the operative mortality risk of patients undergoing thoracic surgery. This study examines the accuracy of Thoracoscore in predicting postoperative mortality in patients undergoing pneumonectomy.
INTRODUCTION
Cardiac surgery has few different models of risk assessment in which EuroSCORE [1] and society of thoracic surgeons scoring score [2] are mostly used. However, there was no risk assessment model in thoracic surgery until recently, when a French group published a risk assessment model called Thoracoscore [3] , to predict in-hospital mortality of various thoracic surgical procedures after assessing 15 183 patients, which they validated internally. This scoring system was accepted and adopted very rapidly nationally and internationally. It is now part of the British Thoracic Society [4] and National Institute for Clinical Excellence guidelines of lung cancer [5] to evaluate the risk of operative mortality of patients who are planned for surgical resection. Thoracoscore has been validated by some groups [6, 7] , but these studies have included heterogeneous surgical patients from pleural biopsy to lung resection, and mean Thoracoscore of all procedures was used for validation.
The purpose of this study is to determine the accuracy of Thoracoscore in predicting in-hospital mortality in patients who underwent pneumonectomy. All patients were followed up to October 2010 to assess mid-term mortality in these patients.
MATERIALS AND METHODS

Patient population and data
Two hundred and forty-three patients underwent pneumonectomy for all causes, from January 1998 to March 2008 at our department. The patients' data were collected from department database, patients' notes and their General Practitioners. Thoracoscore was calculated based on the following variables: age, sex, American Society of Anaesthesiologists (ASA) score, performance status classification, dyspnoea score, priority of surgery, procedure class, Diagnosis group and comorbidities as described in the original Thoracoscore [3] . In-hospital mortality was recorded and their survival was obtained from National Database.
Statistical analysis
A C statistic (or the area under the receiver operating characteristic curve (ROC)) was used to assess the discriminatory ability of the model. The area under the ROC was calculated as an index (C statistic) for how well Thoracoscore could discriminate patients who lived and those who died during their hospitalization after thoracic surgery. The discriminative power of the model is thought to be excellent if the area under the ROC is >0.80, very good if >0.75 and good if >0.70. Therefore, this is used to analyse in-hospital mortality in this group of patients. For the multivariate analysis of variables, logistic regression analysis was performed to predict in-hospital mortality. Kaplan-Meier survival plots were constructed for the survival. For further analysis, we classified all the patients into four incremental risk groups (Group 1 1%, Group 2 1-3%, Group 3 3-7% and Group 4 <7%) on basis of Thoracoscore risk prediction as described by Falcoz et al. in their original study model. Pneumonectomy is a high-risk procedure and Second National Surgery Database report 2011 of Society for Cardiothoracic Surgery of Great Britain and Ireland has shown that operative mortality of pneumonectomy mortality of the UK has been 5-6% in the last 5 years. Therefore, we modified the risk groups with different values of Thoracoscore for the risk categories. Group 1 is a low-risk (≤3) group; Group 2 is moderate (3.1-5), Group 3 is high (5.1-8) and Group 4 is a very high-risk (>8) group, and these groups were evaluated for observed in-hospital mortality vs predicted in-hospital mortality and further assessed for long-term survival in each group.
RESULTS
Two hundred and forty-three patients underwent pneumonectomy. Almost all of the patients (96%) were operated for lung cancer. One hundred and ninety-seven (81%) patients were male and the median age of all patients was 64 ± 9 years (22-82 years) ( Table 1 ). The mean predicted in-hospital mortality based on Thoracoscore was calculated as 8 ± 2.6% (95% CI 4.56-11.43). However, actual in-hospital mortality was observed in 4.5% (11 patients, 95% CI 1.87-7.12). In the first half of the study, we performed 138 (57%) pneumonectomies with 5% (7/11) mortality, while in the second half we performed 105 (43%) pneumonectomies with 3.8% (4/11) mortality. Perioperative management and selection criteria during the study were always the same as guided by British Thoracic Society. Thoracoscore predicted 8.1% risk for the first half and 7.89% for the second half of the study. The discriminatory ability of Thoracoscore in this group of patients for in-hospital mortality was not satisfactorily measured by the C statistic/ROC curve (area under the receiver operator characteristic curve (AUC) = 0.44) ( Fig. 1 ). Eight of 11 patients (82%), who died in hospital, had right pneumonectomy, 6 patients (54%) were over the age of seventy, 8 (73%) were male and 9 (82%) were operated on for lung cancer. There were 197 males and 46 females, and their mean predicted mortalities were 8.7 and 5.2% while their observed mortalities were 4 and 6.5%, respectively. Similarly, the mean predicted mortality in age groups of <55, 55-65 and >65 years were 3.77, 8.04 and 9.59% while the observed mortalities were 8.3, 2.7 and 6%, respectively.
The Thoracoscore model was built to predict mortality in a very mixed (heterogeneous) patient population. The nature of pneumonectomy and the process of patient selection have reduced that variability to just age and sex. The Thoracoscore factors are too homogeneous (same) in this specific group. This can be seen in the predicted mortality rates being within a very narrow range, roughly 3.4-12.7, with most in the region of 7-10%. The patients are all ASA ≥3 because they have a pneumonectomy, almost invariably or cancer. Similarly, they are elective, performance status ≤2, dyspnoea status ≤2 and comorbidity score ≤2 because they have been selected to be so; patients with higher scores are turned down as too high risk. Univariate and multivariate analyses by logistic regression for 30-day mortality revealed that only the dyspnoea status is significant in the univariate analysis. No variables are significant in the multivariate analysis. This is likely because this group of patients are themselves a select group from the Thoracoscore and hence applying an analysis of the Thoracoscore on a variable/group within the Thoracoscore is going to yield problems. Further to this, the ASA status, performance status, priority of surgery, procedure performed and comorbidities are constant for all patients, so will not affect mortality ( Table 2) . Incremental risk groups were analysed for observed in-hospital mortality and mid-term survival. The patients were divided into risk groups as described by Falcoz et al., and analysed for predicted and observed mortality. There was no patient in risk Group 1, 12 patients were in Group 2 with 2.58 vs 17%, 58 patients in Group 3 with 4.78 vs 3% and 172 patients in Group 4 with 9.52 vs 4%, respectively. The observed mortality was significantly different from predicted mortality ( Table 3 ). Our modified risk groups determined that the low-risk group consists of 12 (5%) patients and 2 (17%) patients died in hospital, which is significantly higher than predicted by Thoracoscore (2.7%). Moderate-and high-risk groups consisted of 36 (15%) and 32 (13%) patients, respectively, and 2 patients in moderate-risk group (observed 5.5% and predicted 4.1%) and 1 patient in high-risk group (observed 3% and predicted 6.24%) died in hospital. 163 patients (67%) were in the very high-risk group and only 6 patients (observed 3.7% and predicted 9.66%) died in this group (Table 4 ). Those 2 patients who died in low-risk groups were operated urgently (during same admission) for septic non-malignant pathology. This study determined that Thoracoscore failed to predict the accurate risk of in-hospital mortality in each group of original risk groups while in our modified risk groups we found similar discrepancies between observed and predicted mortality except for the moderate-risk (Fig. 2) . Cox regression for long-term survival of pneumonectomies revealed that age, dyspnoea status and Thoracoscore were the important predictors of long-term survival ( Table 5 ). Survival comparison of incremental risk groups shows poor 5-year survival (25%) in the very high-risk group (Fig. 3 ).
DISCUSSION
The Thoracoscore risk model has been designed to predict in-hospital postoperative mortality of the patients who were operated on for thoracic surgical procedures [3] . This model should predict accurately in a wide range of thoracic surgical procedures, from small to invasive procedures. It has been accepted and adopted broadly across the world. This model was used to assess the clinical outcome in an objective risk-adjusted manner. It has been validated internally and externally [6, 7] . It has been tested for prediction of mid-term mortality which has shown that it can envisage mid-term mortality [7] . These studies included all thoracic surgical procedures in their analysis while the numbers of high-risk surgical procedures like lung resections, especially pneumonectomy, were limited. We conducted our study to validate the Thoracoscore in one group of patients who underwent very high-risk surgical procedure, i.e. pneumonectomy and to determine the accuracy of the Thoracoscore model in this group of patients. The mean risk of in-hospital mortality based on Thoracoscore was calculated as 8 ± 2.6% in these patients while the actual observed mortality in these patients was 4.5%, which is significantly lower than predicted. ROC curve analysis failed the discriminatory ability of Thoracoscore in pneumonectomy patients for in-hospital mortality (C index 0.44) and mid-term morality (C index 0.60). This model shows the Thoracoscore inability to predict outcomes accurately in this group of patients. Falcoz et al. [3] analysed >15 000 patients to develop Thoracoscore model to predict in-hospital mortality and included all thoracic surgical procedures. However, there were only 6% of patients in this model who underwent pneumonectomy and in-hospital mortality was 7.3% in this group. This figure has become the basis of the model, proving pneumonectomy to be the highest risk procedure. In their validation of the risk model, it was revealed that only 6% of patients underwent pneumonectomy and C index was 0.65 with a large CI. This validation itself shows that this model is less sensitive for pneumonectomy patients. No other specific validation has been done yet for this group of patients. Incremental risk groups' analysis of observed and predicted outcomes demonstrated that the observed in-hospital mortalities in our study were not comparable with the predicted mortalities by Thoracoscore. It over-predicted for the high-risk groups while under-predicting for the low-risk group. Most of our patients were in the very high-risk group (67%) but observed mortality was only 3.7%, which was less than half of the predicted mortality (9.6%) for this group. Nonetheless, long-term survival is poor in this group. Bernard and Falcoz group further developed and validated another risk model of in-hospital mortality after pulmonary resection from the French national database, Epithor, published in 2011 [8] . In this risk model, they added further variables like FEV1, body mass index, side, extended resection, stage, chronic bronchitis, cardiac arrhythmia and prior thoracic surgery. The first analysis included variables as independent predictive binary comorbidities (Model 1) and the second analysis included the number of comorbidities per patients (Model 2). A total of 18 049 lung resections for non-small lung cancer were evaluated, and among them 3037 patients underwent pneumonectomy. However, in-hospital mortality for pneumonectomy was 7.7%, which is similar to that obtained in their earlier model (7.3% ). This study also showed that in-hospital mortality for lobectomy was 3% and for limited resection was 2.4%, which is slightly higher compared with UK practice. While the UK national thoracic national database 2011 reported in-hospital mortalities for limited resection, lobectomy and pneumonectomy were 0.7, 2 and 6.5%, respectively, whereas our institute's in-hospital mortality for lung cancer surgery was only 3.8%. This difference of in-hospital mortality could be possible due to different patient population or characteristic of disease across the channel. Bradley et al. [9] reported in December 2012 on a prospective observational study to evaluate the validity of Thoracoscore for in-hospital mortality and postoperative pulmonary complications. This study of 703 patients who underwent lung resection over a 42-month period observed 16 (2%) in-hospital deaths, and 128 patients developed postoperative pulmonary complications. In a logistic regression analysis, the Thoracoscore was not a significant predictor of mortality (odd ratio [OR] 1.07, 95% CI 0.99-1.17; P = 0.11) but was a significant predictor of postoperative complications (OR 1.08, 95% CI 1.03-1.13; P = 0.002). However, the AUC for the Thoracoscore was 0.68 (95% CI 0.56-0.80) for predicting mortality and 0.64 (95% CI 0.59-0.69) for postoperative complications, indicating poor discriminative and predictive ability for mortality and postoperative complications following elective lung resection [9] . However, it has to be stated that Thoracoscore was not designed for the prediction of postoperative complications.
In thoracic surgery, especially lung cancer surgery, it is very crucial to estimate in-hospital, short and long-term mortality and survival to monitor outcome, quality of care and effectiveness of various procedures. In this retrospective study, Thoracoscore failed to predict accurate in-hospital mortality for patients who underwent a pneumonectomy. However, this study determined that long-term survival could be anticipated. It was not the purpose of our study to make this model controversial but to evaluate this model against different surgical procedures separately. As we learnt from EuroSCORE in cardiac surgery, continuous evaluation of EuroSCORE not only improved risk stratification but also evolved from EuroSCORE to logistic EuroSCORE and logistic EuroSCORE to EuroSCORE 2. As pneumonectomy is a high-risk procedure, we should consider more variables to stratify the risk in high-risk procedures as has been integrated in EuroSCORE.
In conclusion, it is possible that Thoracoscore could not be accurate in each surgical procedure, as we have shown in our study. Although there are some limitations in our study as it is a retrospective study and the number of patients in our risk-group model varies, we possibly have identified a subset of thoracic surgical patients where Thoracoscore does not accurately predict mortality since this is one of the major variables in the Thoracoscore. Therefore, further studies may require a more rigorous evaluation of the Thoracoscore in different subsets of thoracic surgery and this four risk-group model.
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